Cancer immunotherapy has become an important area of cancer treatment. Unlike treatments that directly target or destroy rapidly dividing cells, immunotherapy works by helping the immune system identify and respond to cancer cells. It may be used alone or alongside treatments such as surgery, chemotherapy, radiation therapy, or targeted therapy. The benefits and risks can vary depending on the individual and the specific type of treatment.
The immune system normally helps protect the body from infections and abnormal cells. However, cancer cells can sometimes avoid immune detection or suppress immune responses. Certain immunotherapy treatments are designed to improve the immune system’s ability to recognize and attack these cells.
For some people, immunotherapy can produce meaningful and sometimes long-lasting treatment responses. It has been used for several types of cancer, although it is not suitable or equally effective for every patient. Treatment decisions are usually based on factors such as cancer type, stage, biomarker results, previous treatments, and overall health.
Potential benefits may include:
Common forms of immunotherapy include immune checkpoint inhibitors, monoclonal antibodies, cancer vaccines, and certain cellular therapies. Each treatment works differently and has its own potential benefits and limitations.
Although immunotherapy can be beneficial for some patients, it can also cause side effects. Because these treatments influence immune activity, the immune system may sometimes affect healthy organs and tissues. The type and severity of side effects can differ widely between individuals.
Possible risks and side effects may include:
Healthcare teams typically monitor patients during treatment to identify side effects early. Some immune-related reactions may require treatment delays, medicines that reduce immune activity, or other medical interventions. Patients should report new or worsening symptoms to their healthcare provider rather than attempting to manage potentially serious symptoms on their own.
Cancer immunotherapy continues to expand treatment possibilities for certain cancers, but its effects vary from person to person. Understanding both the potential benefits and possible risks can support informed discussions with oncology professionals. Treatment choices should be based on an individual evaluation of the cancer, available test results, medical history, and potential response to therapy.